CN Stock MarketDetailed Quotes

688046 GemPharmatech

Watchlist
  • 14.79
  • +2.08+16.37%
Market Closed Sep 30 15:00 CST
6.06BMarket Cap38.42P/E (TTM)

GemPharmatech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

GemPharmatech Q2 2024 Earnings Date

Currency：CNYAug 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
183.30M
--
+17.83%
Net Income
--
46.86M
--
+0.73%
Analyst Rating
Strong Buy

Oct 5, 2024

GemPharmatech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Apr 27, 20242024/Q1157.087M / 154.000M--
DatePeriodRevenue/EstimateEarnings Call
Apr 27, 20242024/Q1157.087M / 154.000M--

GemPharmatech Earnings Reports

  • Yakkang Biotech 2024 Semi-Annual Report

    Aug 28 12:00 ET

  • Summary of Yakkang Biotech\'s 2024 Semi-Annual Report

    Aug 28 12:00 ET

  • Yakkang Biotech 2023 Annual Report

    Apr 26 12:00 ET

  • Summary of Yakkang Biotech's 2023 Annual Report

    Apr 26 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 5, 2024

    Strong Buy

    • Strong Buy

      69.23%

    • Buy

      30.77%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data